Working… Menu

Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02278315
Recruitment Status : Active, not recruiting
First Posted : October 30, 2014
Last Update Posted : April 9, 2020
Information provided by (Responsible Party):
Cellectar Biosciences, Inc.